Asia-Pacific Americas Africa Europe Middle East

HANALL BIOPHARMA

Company Profile:

HANALL BIOPHARMA Company Introduction

Company Type: Manufacturer (Pharmaceutical Company)

HANALL BIOPHARMA is a South Korean pharmaceutical company primarily engaged in the research, development, manufacturing, and commercialization of innovative pharmaceutical products. Founded in 1973, the company focuses on creating novel drugs to address unmet medical needs, particularly in areas such as immunology, ophthalmology, and oncology. They operate their own facilities for drug discovery, development, and production. Therefore, HANALL BIOPHARMA is a manufacturer, not a trading company. They are involved in the entire lifecycle of pharmaceutical products from invention to market.

Enterprise Products

HANALL BIOPHARMA Products:

* SUSTIVA (Efavirenz)

* FORTEO (Teriparatide)

* REMICADE (Infliximab)

* GLARGIN (Insulin Glargine)

* NESP (Darbepoetin Alfa)

* ALLERGAN AESTHETICS (Botulinum Toxin, Dermal Fillers)

* Various Over-the-Counter (OTC) Products and Health Supplements

Business Registration Information:

Manager:

Seung-Wook Park
Phone:

No Data
E-mail:

ir@hanall.co.kr
Official Website:
Address:

5F, Hanwha Life Insurance Building, 470, Deokgogae-ro, Jungwon-gu, Seongnam-si, Gyeonggi-do, 13200, Republic of Korea
This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.